Resorcylidene aminoguanidine improves the pathologically reduced fluidity of erythrocyte membranes in diabetes mellitus.

Authors	L Sikurová, J Dérerová, P Kvasnicka, I Waczulíková, J Cársky, O Ulicná
Journal	Die Pharmazie (Pharmazie) Vol. 55 Issue 9 Pg. 700-1 (Sep 2000) ISSN: 0031-7144 [Print] Germany
PMID	11031780 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Guanidines resorcylidene aminoguanidine
Topics	Anisotropy Diabetes Mellitus, Type 1 (blood) Erythrocyte Membrane (drug effects, physiology) Guanidines (pharmacology) Humans In Vitro Techniques Membrane Fluidity (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!